Publications by authors named "Simona Bassi"

Claim this Profile
T
Trends in GVHD Epidemiology, Prophylaxis and Management: The Gruppo Italiano per il Trapianto di Midollo Osseo, Cellule Staminali Emopoietiche e Terapia Cellulare (GITMO) GVHD24 Study.
Nicola Polverelli, Caterina Zerbi, Maria Grazia Benevento, Mattia Algeri, Alessandra Algarotti, Simona Bassi

Am J Hematol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcome of Patients With Acute Myeloid Leukemias or Myelodysplastic Syndromes After Relapsing From Allogeneic Stem Cell Transplantation: The GITMO AML/MDS-Relapse Registry Study.
Michele Malagola, Luca Castagna, Domenica Matranga, Vera Radici, Mirko Farina, Simona Bassi

Am J Hematol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of frailty and comorbidities in cellular therapies patients in Italy: results of the GITMO Elderly-Survey (GITMO ELD-Survey).
Michele Malagola, Luca Castagna, Mirko Farina, Simone Pellizzeri, Eliana Degrandi, Simona Bassi

Leuk Lymphoma· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Busulfan or Treosulfan Conditioning Platform for Allogeneic Stem Cell Transplantation in Patients Aged >60 Y With Acute Myeloid Leukemia/Myelodysplastic Syndrome: A Subanalysis of the GITMO AlloEld Study.
Michele Malagola, Nicola Polverelli, Massimo Martino, Francesca Patriarca, Benedetto Bruno, Simona Bassi

Transplant Direct· March 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mixed T cell CHIMERISM in bone marrow at day+30 after allogeneic stem cell transplantation: Correlation with acute GVHD grades III-IV and no impact on relapse and overall survival.
Samantha Guidotti, Simona Bassi, Angela Rossi, Elena Borotti, Pilade Cortellazzi

Eur J Haematol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GITMO Registry Study on Allogeneic Transplantation in Patients Aged ≥60 Years from 2000 to 2017: Improvements and Criticisms.
Michele Malagola, Nicola Polverelli, Vicky Rubini, Massimo Martino, Francesca Patriarca, Simona Bassi

Transplant Cell Ther· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Ibrutinib as a bridge to transplant in high-risk chronic lymphocytic leukemia: A case report and review of the literature.
Arcari Annalisa, Bassi Simona, Pochintesta Lara, Trabacchi Elena, Moroni Carlo Filippo

Leuk Res Rep· November 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and efficacy of granulocyte colony-stimulating factor biosimilars in engraftment after autologous stem cell transplantation for haematological malignancies: a 4-year, single institute experience with different conditioning regimens.
Simona Bassi, Elisa M Stroppa, Carlo F Moroni, Maria C Arbasi, Elena Trabacchi

Blood Transfus· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fatherhood during imatinib.
Emad Shash, Simona Bassi, Emilia Cocorocchio, Giovanni Maria Colpi, Saverio Cinieri

Acta Oncol· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A single dose of Pegfilgrastim versus daily Filgrastim to evaluate the mobilization and the engraftment of autologous peripheral hematopoietic progenitors in malignant lymphoma patients candidate for high-dose chemotherapy.
Simona Bassi, Cristina Rabascio, Luca Nassi, Sara Steffanoni, Aleksandra Babic

Transfus Apher Sci· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up of patients with follicular lymphoma receiving single-agent rituximab at two different schedules in trial SAKK 35/98.
Giovanni Martinelli, Shu-Fang Hsu Schmitz, Urs Utiger, Thomas Cerny, Urs Hess, Simona Bassi

J Clin Oncol· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab and subcutaneous cladribine in chronic lymphocytic leukemia for newly diagnosed and relapsed patients.
Paola Bertazzoni, Cristina Rabascio, Federica Gigli, Liliana Calabrese, Davide Radice, Simona Bassi

Leuk Lymphoma· August 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rituximab in lymphocyte-predominant Hodgkin disease.
Hatem A Azim, Giancarlo Pruneri, Emilia Cocorocchio, Saverio Cinieri, Paola R Raviele, Simona Bassi

Oncology· January 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chronic myeloid leukemia in blast crisis treated with imatinib 600 mg: outcome of the patients alive after a 6-year follow-up.
Francesca Palandri, Fausto Castagnetti, Nicoletta Testoni, Simona Luatti, Giulia Marzocchi, Simona Bassi

Haematologica· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of age on the outcome of patients with chronic myeloid leukemia in late chronic phase: results of a phase II study of the GIMEMA CML Working Party.
Gianantonio Rosti, Ilaria Iacobucci, Simona Bassi, Fausto Castagnetti, Marilina Amabile

Haematologica· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving a major molecular response at the time of a complete cytogenetic response (CCgR) predicts a better duration of CCgR in imatinib-treated chronic myeloid leukemia patients.
Ilaria Iacobucci, Giuseppe Saglio, Gianantonio Rosti, Nicoletta Testoni, Fabrizio Pane, Simona Bassi

Clin Cancer Res· May 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ABL mutations in late chronic phase chronic myeloid leukemia patients with up-front cytogenetic resistance to imatinib are associated with a greater likelihood of progression to blast crisis and shorter survival: a study by the GIMEMA Working Party on Chronic Myeloid Leukemia.
Simona Soverini, Giovanni Martinelli, Gianantonio Rosti, Simona Bassi, Marilina Amabile

J Clin Oncol· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Imatinib and pegylated human recombinant interferon-alpha2b in early chronic-phase chronic myeloid leukemia.
Michele Baccarani, Giovanni Martinelli, Gianantonio Rosti, Elena Trabacchi, Nicoletta Testoni, Simona Bassi

Blood· December 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular response to imatinib in late chronic-phase chronic myeloid leukemia.
Gianantonio Rosti, Giovanni Martinelli, Simona Bassi, Marilina Amabile, Elena Trabacchi

Blood· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy with autologous transplantation for aggressive non-Hodgkin's lymphoma: the Bologna experience.
Pier Luigi Zinzani, Monica Tani, Annalisa Gabriele, Filippo Gherlinzoni, Antonello De Vivo, Simona Bassi

Leuk Lymphoma· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High-dose therapy with autologous transplantation for Hodgkin's disease: the Bologna experience.
Pier Luigi Zinzani, Monica Tani, Annalisa Gabriele, Filippo Gherlinzoni, Antonio de Vivo, Simona Bassi

Haematologica· May 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk and early cytogenetic response to imatinib and interferon in chronic myeloid leukemia.
Gianantonio Rosti, Elena Trabacchi, Simona Bassi, Francesca Bonifazi, Antonio de Vivo

Haematologica· March 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis